Health · 1 sources covering this

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·53m ago
STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/ad644a25e5e780d56d1560ee4d242c52071efe92"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy"></iframe>

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

How 1 sources are covering this

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

More from Health

STAT+: Stunning $6M defamation verdict reverberates at MIT campus, global scientific community

STAT+: Two No Surprises Act arbitrators lose government contracts to decide payment disputes

Opinion: MAHA 1.0 is dead. MAHA 2.0 is born

STAT+: A possible comeback for a failed sickle cell gene therapy

Reader

Trust & legal

Across the network